|
|||
|
Multiple Sclerosis Info
If you want this blog to continue, than make it financialy viable for Bonnie to continue it. She puts in 2-3 hours a day into this blog, and spends money on it for it's upkeep.
Search
This Month
|
Thursday, August 14
by
All About MS
on Thu 14 Aug 2008 09:38 AM CST
BioMS Medical Corp. (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), announced that the independent Drug Safety Monitoring Board (DSMB) for the MAESTRO-01 trial has conducted the scheduled interim analysis of efficacy and safety and has recommended that the trial continue to completion.
MAESTRO-01 is the pivotal phase II/III Canadian and European study of Dirucotide (MBP8298) in patients with secondary progressive MS.
The interim analysis included more »
Sunday, August 10
by
All About MS
on Sun 10 Aug 2008 12:00 AM CST
In adult patients, autoantibodies targeting the water channel aquaporin-4 (AQP4) are a biomarker for a spectrum of CNS inflammatory demyelinating more »
|
||